Three Bloomberg School Faculty Elected to National Academy of Medicine
Three Johns Hopkins Bloomberg School of Public Health professors have been elected to the National Academy of Medicine, along with two colleagues from the Johns Hopkins University School of Medicine.
Membership in the NAM, considered one of the highest honors in the fields of health and medicine, recognizes individuals who have demonstrated outstanding professional achievements and commitment to service. The announcement was made during the NAM’s annual meeting in Washington, D.C., on October 20. This year’s class includes 100 new members.
“We are proud to have three of our faculty recognized by the Academy for their groundbreaking and influential public health work,” says Keshia Pollack Porter, PhD, MPH, Bloomberg School Dean and Bloomberg Centennial Professor. “Through their scholarship and leadership, they are shaping the future of their fields and helping us deliver on our School's mission of improving health for all people.”
The Bloomberg School’s NAM Class of 2025:
Pamela Collins, MD, MPH, is a Bloomberg Centennial Professor, chair of the Department of Mental Health and director of the Johns Hopkins Center for Global Mental Health. She works at the intersections of global mental health, HIV care, and urban health for adolescents and adults. Her current projects integrate psychosocial interventions into routine HIV care for adolescents living with HIV and into community-based care with faith-based providers in sub-Saharan Africa, and she explores urban responses to youth mental health needs in the U.S. Through leadership at the National Institute of Mental Health, she launched research initiatives to build the evidence base for integration of mental health interventions into HIV care, primary care, maternal health services, and chronic disease care in low- and middle-income countries. Collins is a scientific advisor to PEPFAR, the U.S. President's Emergency Plan for AIDS Relief program, and has served on the National Advisory Mental Health Council. She is a co-director of the Johns Hopkins-Emory University Center for HIV and Mental Health Stigma Elimination Strategies. She has a joint appointment at the Johns Hopkins University School of Medicine.
Collins earned her MD from Weill Cornell Medical College, an MPH from Columbia University Mailman School of Public Health, and a BA from Purdue University.
Elizabeth A. Stuart, PhD, AM, is the Frank Hurley and Catharine Dorrier Professor and Chair in the Bloomberg School’s Department of Biostatistics. She develops and uses statistical methods to help learn about the effects of public health programs and policies, with applications across public health, including mental health, substance use, and violence prevention. Her current research projects include developing approaches for personalized public health using multiple data sources, designing methods for assessing and enhancing the generalizability of randomized trial results to target populations, and partnering in collaborations estimating the effects of state policies. Stuart has been recognized on the Clarivate Highly Cited Researchers lists (top 1% of citations) since 2021, and was part of the team that won the 2025 Outstanding Statistical Application Award from the American Statistical Association for work estimating the effects of abortion restrictions in the U.S. Stuart has joint appointments at the Bloomberg School’s departments of Health Policy and Management and Mental Health. She previously served as executive vice dean for Education at the Bloomberg School.
She earned her PhD and an AM in statistics from Harvard University, and a BA in mathematics from Smith College.
Donald Warne, MD, MPH, (Oglala Lakota), serves as co-director of the Johns Hopkins Center for Indigenous Health and is a tenured full professor at the Bloomberg School of Public Health, where he also served as Provost Fellow for Indigenous Health Policy. A leading physician and one of the world’s foremost scholars in Indigenous health, education, policy, and equity, Warne recently led the development of new Doctor of Public Health and Master of Public Health Indigenous Health concentrations at the Bloomberg School, both launching in the 2026–2027 academic year. His current research includes chronic disease prevention, and advancing health equity through community-driven, culturally grounded approaches. An enrolled member of the Oglala Lakota Tribe from Pine Ridge, South Dakota, Warne comes from a long line of traditional healers and medicine men. He also serves as senior policy advisor to the Great Plains Tribal Leaders Health Board. Warne’s career spans clinical care, policy, and academia; highlights include his roles as founding chair of the departments of Public Health and Indigenous Health at North Dakota State University and University of North Dakota.
Warne earned an MD from Stanford University School of Medicine, an MPH from the Harvard T.H. Chan School of Public Health, and a BS from Arizona State University.
Charlotte J. Sumner, MD, a professor in the Johns Hopkins University School of Medicine's departments of Neurology, Neuroscience, and Genetic Medicine, and Victor E. Velculescu, MD, PhD, a professor of oncology, pathology, medicine, and genetic medicine at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, were also elected to the NAM this year.
Since the NAM’s founding in 1970, the work and recommendations of its members have shaped health research, practice, and policies that improve health and health outcomes worldwide.
New members are elected by current members through a selective process that recognizes people who have made major contributions to the advancement of medical sciences, health care, and public health. The NAM currently has more than 2,000 members.
# # #
Media contacts: Kris Henry at khenry39@jhu.edu and Barbara Benham at bbenham1@jhu.edu.